Komori
Jeol (6951) · FactReframed

Transition to a structure with a chair and CEO and a president and COO

First written in FY2019. 2 of 3 entries say "Reframed", first in FY2023. Latest entry: FY2024.

3entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019ReframedFY2023 – FY20242019: 120192020: 020202021: 020212022: 020222023: 120232024: 12024
Same theme, other companies

Jeol moved to the "Worse" side of this theme in 2023, 2 years before the typical company in this theme (2025).

The whole theme swung hardest in 2022: 1 of 7 companies on the "Worse" side.

9 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 34 companies compared. The sentences above are computed from all 34.
Moved together

"Decline in profit in the Medical Equipment business" moved the same way as this thread, in the same document, in 2 of its 3 moves.

222★123
  1. ★This thread
  2. 1Decline in profit in the Medical Equipment business2×
  3. 2Recording of ¥159 million in impairment loss2×
  4. 3Weak overseas OEM orders and sales from Siemens2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Jeol's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.